DNA sequencing
250,000 DNA samples and 2.8m patient records to power medical industry
April 16 by Chanice HenryTo fast-track the development of innovative medicines, a biotech start-up is opening access to its extensive genomic and bioinformatics resources.
Angelina Jolie and the Maturity of Genomics
May 16 by Gerald ClarkeThe extraordinary and brave decision of Angelina Jolie to publish an op-ed in the New York Times about her decision to undergo a preventative double mastectomy in response to learning that she carri...
Why Not Sequence the Whole Genome?
September 13 by Andrea CharlesProfessor René Bernards, Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-ge...
How Pharma is Heading for the Clouds
August 23 by Pharma IQIn an industry in which research is currency and vast amounts of data hold the key to millions being added to the bottom line, a solution which allows information to be stored and accessed more easi...
An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 1 - DNA Sequencing
April 13 by Pharmaceuticals & Biotechnology EditorGerd Maass, Vice President for R&D at Roche Pharmaceuticals, shares his views on advances in companion diagnostics, DNA sequencing and biobanking. This segment on DNA sequencing addresses claims t...
What’s New in Human Genome Research?
February 02 by Helen WinsorJeffrey A. Schloss, Program Director for Technology Development Co-ordination at the National Human Genome Research Institute at the National Institute of Health, joins Pharma IQ to discuss developm...
How to Overcome Challenges with siRNA Targeting
December 13 by Pharma IQProfessor Ann Logan, Lead Professor, University of Birmingham, joins Helen Winsor Pharma IQ, to discuss next-generation DNA sequencing. Logan reports on her laboratory’s primary research into the...
Accelerating Biological and Biomedical Research
November 30 by Pharma IQThe outlook for genome research looks bright. A technological evolution in the past few years has reduced the cost of DNA sequencing, accelerating the possibilities for future rese...
New Genome Study Sheds Light on Biopatents
August 23 by Pharma IQFor pharmaceutical companies, the development of effective and binding patents is often key to their efforts to successfully bring new products to the market. However, it is an understatement to sugg...
Using Next-Generation DNA Sequencing Methods
August 08 by Pharma IQAlthough more than a thousand bacterial genomes have been sequenced, our understanding of bacterial transcriptomes has lagged far behind. Transcript structure, operon linkages, and absolute mRNA ...